Myriad Genetics, Inc.MYGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank36
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P36
Within normal range
vs 5Y Ago
-0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-12.79%
202452.02%
2023-83.07%
202226.19%
20212.21%
202015.93%
2019-3148.68%
2018-93.60%
2017140.28%
2016-70.38%